In the single radial enzyme-diffusion (SRED) method for assay of deoxyribonuclease I, a precisely measured volume of the enzyme solution is dispensed into a circular well in an agarose gel layer in which DNA and ethidium bromide are uniformlydistributed. A circular dark zone is formed as the enzyme diffuses from the well radially into the gel and digests substrate DNA. DNase I and report on the use of this method for measuring the enzyme in human tissues and body fluids.
generally considered mainly a digestive enzyme. However, DNase I activity has been found in nondigestive tissues such as human kidney and liver (3, 4) , which suggests that the biological role of DNase I has not been fully clarified. Some reports have identifiedother func- tions for this enzyme: (a) DNase I binds specifically to G-actin reducing the viscosity of sputum from patients with cystic fibrosis (9) . Although DNase I activity has been identified in several tissues and body fluids (3) (4) (5) (10) (11) (12) (13) (14) , the distribution of the enzyme in the human body has not been systematically and quantitatively investigated. This is due, in part, to the lack of a simple and sensitive quantitative assay method. In this report we describe a new microdetermination method (single radial enzyme-diffusion, SEED) for Department of Legal Medicine, Fukui Medical School, Matsuoka-cho, Fukui 910-11, Japan.
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DNase I and report on the use of this method for measuring the enzyme in human tissues and body fluids.
MaterIals and Methods

Reagents
We purified human urine DNase I (1.8 x iO kilounits/g protein) and DNase II (EC 3.1.22.1; 4.6 x iO kilo-units/g protein) as described previously (5, 15) .
Rabbit skeletal muscle G-actin was prepared by the methodof Spudichand Watt (16 Human tissue samples, including brain, heart, lung, liver, pancreas, kidney, spleen, and submandibular gland, from five to seven individuals (ages 9 days to 74 years) were obtained at autopsy within 24 h postmortem. Thymus glands were obtained from eight individuals (ages newborn to 9 years) at autopsy within 60 h postmortem.
The deceased individuals
were kept at room temperature until autopsy. Placentas were obtained at delivery. All tissue samples were shown to be histologically normal and were stored at -80 #{176}C until used.Tissue extract preparations were done at 0-4 #{176}C; tissues were minced, washed with saline to remove excess blood, and then homogenized in 50 mmol/L potassium phosphate buffer, pH 6.5. After centrifugation at 20 000 x g for 15 mm, ainmonium sulfate was added to the supernate to give 85% saturation. The resulting precipitate was dissolved in 20 mmol/L potassium phosphate buffer, pH 6.5, dialyzed in the same buffer, lyophilized, and stored at -20 #{176}C until used. Serum samples were prepared from venous blood collected from healthy unrelated Japanese donors(20 women, ages22-35 years; 81 men, ages 22-51 years). Blood was centrifuged at 1500 x g for 10 miii, and the supernate was stored at -80 #{176}C until used. Erythrocyte samples were obtained from healthy unrelated Japanese donors (five women and six men). Erythrocytes were washed three times in isotonic saline with removal of as much of the supernate as possible,and the resulting packed cells (-1 x iO'#{176} cells) were lysed by freezing and thawing. Leukocytes were prepared from heparinized blood 5 .4 mL of 20 g/L molten agarose GP-36 (Nacalai Tesque, Kyoto, Japan) in distilled water at 50#{176}C was added and immediately poured onto a horizontal Agafix MSL sheet (Wako Pure Chemical Industries, Osaka, Japan) or agarose-coatedpolyester GelBond film (Pharmacia LKB). The final volume (10.8 mL) was sufficient to prepare a gel plate measuring 7.5 x 13.5 cm and 2 mm thick. After congelation at room temperature, a row of cylindrical sample wells (radius [r0] = 1.0 mm) with centers 15 mm apart was punched in the gel. A 7.5 x 13.5 cm gel plate accommodated 32(4 x 8) samples. Unknown samples (2 izL) and serial dilutions of purified urine DNase I of known activity were placed in the wells with a micropipet. The 2-pL sample solutions filled the wells almost to the brim. The gel plate was incubated in a moist chamber at 37#{176}C, and DNase I activity was observed periodically with an ultraviolet transilluminator at 312 mu (Model TF.1OM; Vilber Lourmat, Marne La Vall#{233}e, France). A circular dark zone formed as the DNase I diffused radially from the well and digested the DNA substrate.
Incubation was continued until test samples gave welldefined dark circles with radii (re) of 2.5-8.5 mm. Differences in length of 0.1 mm were determined with a vernier micrometer. A standard curve was constructed by plotting log10DNase I activity against the diffusion radius (r -r0). The assay gels could be preserved for at least 1 month after drying at 50#{176}C.
We examined the relation between the amount of DNase I applied to the gel plate in the SRED method and the size of the dark circle produced by the diffused enzyme as follows: We prepared the gel plate as described above, except that cylindrical wells with two different radii (r0 = 1.0 and 1.5 mm) were punched in the gel. Known units of purified human urine DNase I in different volumes (u8 = 2.0 to 6.0 1zL) of 10 mmol/L Trismaleate, pH 6.5, containing 5 mmol/L CaCl2, were dispensed into the wells. The gel plate was incubated at 37#{176}C for 20 hand then observed with an ultraviolet light transifluminator. We plotted the logarithm of the units of DNase I dispensedagainst the diffusion radius (re -r0).
To determine DNase I activity in biological samples, we dissolved lyophilized tissue extracts and saliva samples at 10-20 g/L in 10 mmol/L Tris-maleate, pH 6.5, containing 5 mmol/L CaCl2. Urine samples were dissolved in the same buffer at 0.10-0.15 g/L, and semen and erythrocyte lysates were diluted 10-fold in the same buffer. Sera, leukocyte lysates, and breast milk were not diluted. We placed 2 pL of sample solution in the wells, and incubated the gel plates at 37#{176}C for 20 h. The radius of each dark circle was then measured. When sample activity was weak or not detectable, incubations were continued for an additional 24 h.
Effects of EDTA and G-Actin on DNase Activity
We investigated the effect of EDTA on the SRED DNase I assay by adding 10 mmol/L EDTA to the reaction buffer instead of 20 mmoIJL MgCl2 and 2 mmolfL CaCl2. We analyzed the effect of G-actin by adding G-actin and ATP (disodium salt, grade I, Sigma), an inhibitor of polymerization of the actin, to the molten gel to give final concentrations of 20 mg/L and 0.5 mmol/L, respectively.
ConventionalDNase I Assays and Unit Definitionfor DNase I
We used two different assays. In the first, the precipitation assay (5, 11), salmon testis DNA was digested with test samples of DNase I. Soluble DNA fragments were then measured at 260 mu after precipitation with ethanol. We also used the hyperchromicity assay of Kunitz (18) as modified by Liao (19) .
In this study, DNase I activity is given in Yasuda units. One Yasuda unit of DNase I activity is the amount of enzyme that gives an increase in the absorbance at 260 mu of 1.0 A after 15 mm in the precipitation assay (5). One Yasuda unit of purified human urine DNase I corresponded to -0. 18 Kunitz unit as determined in the hyperchromicity assay.
Assaysand Unit Definitionsfor Other Enzymes
The assay and unit definition for human DNase II were described previously (15) . We determined phosphodiesterases I and II according to the supplier's instructions.
DNase I Phenotyping
We determined the DNase I phenotype of serum samples by polyacrylamide gel isoelectric focusing, followed by electrophoresis (3, 20) .
Protein Determination
We determined proteins by the Bio-Rad protein assay (Bio-Rad, Richmond, CA), using bovine serum albumin as a standard. (Figure 1) . The radius of this dark circle is proportional to the amount of enzyme added to the well (Figure 2). Figure 2 indicates that the radius of the dark circle dependson the amount of active DNase I applied to the well, rather than on the sample volume or on the well size. The diffusion radius (r8 -r0), was linearly proportional to the logarithm of DNase I activity within the range of (0.02-10) x i0 unit after an 8-h incubation. Longer incubations of 20 and 50 h increased assay sensitivity 4-and 10-fold, respectively (Figure 3) . Coefficients of variation (CV, n = 6) at each time point in Figure 3 were within the range of 1.7-4.1% (mean, 2.5%). The lowest limit of detection was 2 x 106 unit with a 50-h incubation. The well. Calculated from the activity of DNase 11(4.6 X 10 units/g protein), this corresponds to 2 ng/well. The optimum pH of DNase II is -5.0 with no activity evident at pH 6.5 in the presence of Ca2 and Mg2 (15,22,23) . Hence, it is likely that the dark zone formation reflected DNase I, not DNase II, activity in crude samples applied to the gel. Phosphodiesterase I is present in human urine (24), but neither authentic phosphodiesterase I from snake venom nor phosphodiesteraseII from bovine spleen (0.4 and 0.9 jig/well, respectively) produced a dark zone when applied to the wells. It has been reported that EDTA abolishes DNase I activity and that G-actin is a potent and specific inhibitor of DNase 1(2,4, b The value corresponded to (65 ± 27) x iO units/g protein.
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5,25).
We found that EDTA completely inhibited purified human urine DNase I in the gel, and G-actin inhibited the DNase I activity by 95%. These inhibition tests confirm that the enzyme detected on the reaction gel plate was indeed DNase I.
DNase I Activity in Tissues and Body Fluids
The DNase I activity of 17 different tissue extracts and body fluids was analyzed by the SRED method. The samples that formed a dark circle on the gel platewere then subjected to inhibition tests with EDTA and G-actin. The activity in all these samples was inhibited by EDTA and G-actin. To use an enzyme as a diagnostic marker or to perform a metabolic study on an enzyme, one must know the normal activity of that enzyme in human serum. Table 1 The intra-individual coefficients of variation in serum DNase I activity were -10% of the mean value. Activities in serum samples from female and male subjects were 3.9 ± 1.3 (n = 20) and 4.6 ± 1.9 unitsfL (n = 81), respectively. Significant phenotype-or sex-related differences in specific activity were not found when the results were analyzed statistically by the two-sample t-test. The level of activity of DNase I in other samples from different tissues and body fluids is summarized in Table 2 . A wide range of DNase I activity was observed. Urine had the highest specific activity of all samples tested.The DNase I activity in semen and saliva was also relatively high.
DIscussIon
Three types of nonradioactive DNase I assays have been reported: the hyperchromicity and the precipitation assays (see Materials and Method.s) and the fluorometric assay (10) . Preliminary attempts to determine DNase I activity in tissue extracts and body fluids by the first two assays were unsuccessful. The sensitivity of both assays was low and most test samples had to be dissolved at high concentrations. This procedure gave rise, occasionally, to chyle-like turbidity that interfered with these spectrophotometric assays. Although the fluorometric assay is reported to be more sensitive than the others, it requires large amounts of pure covalently closed circular DNA of bacteriophage PM2, which is not It can be used to detect accurately a very small amount of enzyme present in concentrated crude samples. Moreover, reagents needed for the SRED method are commercially available and inexpensive, the sample size required is small, and the technical procedures involved are simple. To determine the effect of endogenous DNase I inhibitors on the measurement of DNase I activity in biological samples, we prepared active DNase I by acid extraction (0.125 mol/L H2S04) from tissues and body fluids. This procedure has been commonly used to avoid endogenous inhibition (18). However, the DNase I activity of the samples thus obtained was no higher (in some cases it was even lower) than that of the tissue extracts and body fluids prepared by the method given in the Materials and Methods section. As described previously, we were able to recover known amounts of human DNase I from serum and other body fluids and tissues, quantitatively. Therefore, the influence of endogenous DNase I inhibitors was negligible under the present experimental conditions.
Our data indicate that neither DNase I phenotype nor sex influences serum DNase I activity. However, the number of serum samples in this study was small compared with other studies (13, 14) , and other factors that may influence DNase I activity should be considered.
Measurement
of DNase I activity in many serum and other body fluid samples by the SEED method is under way in our laboratory. As shown in Table 2 , DNase I activity is high in urine. DNase I is thought to be produced in the pancreas, kidney, liver, and other tissues and subsequently released into the bloodstream. It may then be concentrated in the kidney, giving rise to markedly higher concentrations of DNase I in urine than in other body fluids. This mechanism has been reported for other enzymes (26) . We have proposedthat the human DNase I present in various tissues and body fluids might be encodedby the same single gene, becausethe biochemical and genetic properties of this enzyme in urine, serum, pancreas, kidney, and liver are quite similar as described in our previous papers (3) (4) (5) 27) . Leukocyte samples prepared in this study showed no DNase I activity. We do not believe that this is caused by the presence of heparin, which has been described as inhibiting DNase activity (28) , because the leukocytes obtained from heparinized blood were thoroughly washed with isotonic Tris . HC1 buffer before the lysate preparation.
